Skip to main content

Distinguished Speaker Series | Filippo Mancia, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

April 17, 2026 | Filippo Mancia, PhD

The molecular mechanisms underlying cellular uptake of vitamin A

 

Learn More About the Distinguished Speaker Series

Featured


Filippo Mancia, PhD
Filippo Mancia, PhD
  • Filippo Mancia, PhD, Professor, Vice Chair, Director of Graduate Education, Department of Physiology and Cellular Biophysics, Columbia University

Filippo Mancia, PhD, is Professor, Vice Chair, and Director of Graduate Education in the Department of Physiology and Cellular Biophysics at Columbia University. His research focuses on the structural biology of membrane proteins, particularly G protein-coupled receptors (GPCRs) and other signaling complexes that regulate key cellular communication pathways. Dr. Mancia’s laboratory uses advanced structural and biophysical approaches, including X-ray crystallography, cryo-electron microscopy, and biochemical analysis, to understand how these membrane proteins are organized and how they interact with ligands, signaling partners, and regulatory molecules. By revealing the molecular architecture and activation mechanisms of these signaling systems, his work aims to provide deeper insight into fundamental cell signaling processes and to inform the development of therapeutic strategies targeting GPCR-related diseases.